Send to

Choose Destination
See comment in PubMed Commons below
Future Oncol. 2011 Sep;7(9):1113-7. doi: 10.2217/fon.11.89.

Management of metastatic ovarian Sertoli-Leydig cell tumor with sporadic multinodular goiter: a case report and literature review.

Author information

Department of Medicine, Saint Joseph Hospital/University of Illinois at Chicago, 60657, USA. chimingtea@


Information regarding treatment for patients with metastatic ovarian Sertoli-Leydig cell tumor (SLCT) has been extremely limited. We report a young woman whose stage IA, poorly differentiated SLCT was initially managed surgically 9 months earlier, and who presented with extensively metastatic SLCT. She had a dramatic response to the combination of bleomycin, etoposide and cisplatin followed by stem cell transplantation and surgery, and has shown no evidence of disease recurrence for 8 months postoperatively. The patient was also found to have sporadic non-toxic multinodular goiter, which has not changed over the treatment course as mentioned. A review of the literature concerning the management of metastatic ovarian SLCT, along with its coexistence with multinodular goiter, is presented.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center